Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models^†

by Fabien Muselli, Lucas Mourgues, Rita Morcos, Nathalie Rochet, Marielle Nebout, Agnès Guerci, Douglas V. Faller, Robert M. William, Rana Mhaidly, Els Verhoeyen, Laurence Legros, Jean-François Peyron, Didier Mary
Published 2021-04-01